FDA Inspection
SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) – FDA Inspection, Jul 5, 2019
Record Details
This FDA Inspection record concerns SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals), with an inspection on July 5, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 5, 2019
- Product Type
- Biologics
View Company Profile
ID · 63db143a-b785-4875-96d0-efc0ded378e0
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1101506
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 20, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 27, 2017 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 22, 2011 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 24, 2010 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
- FDA Inspection 1233707 - 2024-03-15
- FDA Inspection 1181891 - 2022-09-20
- FDA Inspection 1019795 - 2017-06-27
- FDA Inspection 736162 - 2011-06-22
- FDA Inspection 668686 - 2010-05-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.